Back to calendar
Regeneron Pharmaceuticals, Inc. (REGN) Earnings
REGN reports earnings on Thursday, October 29, 2026
earnings report
October 29, 2026 · Before Market Open
Q3 2026
Est. EPS: $16.00
Actual EPS: $14.29
Company overview
Market Cap$87.1B
SectorHealth Technology
IndustryPharmaceuticals: Major